Financials

ADCI fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to ARAB PHARMACEUTICALS operating, investing, and financing activities

ADCI free cash flow for Q2 25 is -21.49 M EGP. For 2024, ADCI free cash flow was -145.48 M EGP and operating cash flow was 140.5 M EGP.

Q2 '15

Q3 '15

Q4 '15

Q1 '16

Q2 '16

Q3 '16

Q4 '16

Q1 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q1 '20

Q2 '20

Q1 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EGP